Meet the 2023 Lymphoma Scientific Research Mentoring Program Scholars
The Lymphoma Research Foundation’s (LRF) Lymphoma Scientific Research Mentoring Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists who wish to focus on lymphoma and CLL research, whether in the lab or in the clinic.
The primary goal of the LSRMP is to retain its talented participants — called LRF Scholars — in the field of lymphoma by providing mentoring and education programming and fostering research collaboration among expert faculty and grantees.
Led by the 2023 LSRMP Clinical Research co-chairs, Steven Horwitz, MD (Memorial Sloan Kettering Cancer Center) and Nancy Bartlett, MD (Washington University in St Louis), and Laboratory/Translational Research co-chairs, Laura Pasqualucci, MD (Columbia University) and Michael Green, PhD, MD (University of Texas MD Anderson Cancer Center) the new class is boasting translational and clinical researchers pursuing a diverse range of research projects with a goal to improve patient outcomes.
Clinical Research LRF Scholars
Ayushi Chauhan, MD
Stephanie A. Gregory Distinguished Scholar
Augusta University Research Institute, Inc
Research Study: Maintenance Zanubrutinib in Elderly PCNSL unfit for intensive consolidation (MAIZE)
Lymphoma Focus: Primary Central Nervous System Lymphoma
Read full Researcher Spotlight >
Daniel Ermann, MD
The University of Utah
Research Study: Pneumococcal Vaccination Series for Patients with CLL: Can We Prevent Morbidity and Mortality?
Lymphoma Focus: Chronic Lymphocytic Leukemia
Read full Researcher Spotlight >
Julie Erika Haydu, MD, PhD
Runge Lymphoma Project Scholar
Massachusetts General Hospital
Research Study: A Phase 1 Study of CC-99282 and Epcoritamab in Previously Untreated Follicular Lymphoma
Lymphoma Focus: Follicular Lymphoma
Read full Researcher Spotlight >
Swetha Kambhampati, MD
Eric Cohen Distinguished Scholar
City of Hope Comprehensive Cancer Center
Research Study: Loncastuximab Tesirine and Mosunetuzumab in Relapsed/Refractory Diffuse Large B-cell Lymphoma
Lymphoma Focus: Diffuse Large B-cell Lymphoma
Read full Researcher Spotlight >
Christine Ryan, MD
Kanti R. Rai, MD Clinical Scholar
Dana-Farber Cancer Institute
Research Study: Phase 2 Study of Glofitamab in Richter’s Syndrome
Lymphoma Focus: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Read full Researcher Spotlight >
Timothy Voorhees, MD
Schroder Family Scholar
The Ohio State University College of Medicine
Research Study: Phase Ib Study to Assess the Safety and Efficacy of Epcoritamab in Relapsed and Refractory PTLD
Lymphoma Focus: Post-Transplant Lymphoproliferative Disorders
Read full Researcher Spotlight >
Laboratory/Translational Research LRF Scholars
Ajilan Al Zaki, MD, PhD
MD Anderson Cancer Center
Research Study: Imaging Activated Macrophages and Neutrophils in CAR T-Cell-Associated Neurotoxicity Using [18F]4FN
Lymphoma Focus: B-cell Lymphomas, Non-Hodgkin Lymphomas
Read full Researcher Spotlight >
Alexander Boardman, MD
Dobosh Family Scholar
Memorial Sloan Kettering
Research Study: Targeting CD24 in Lymphoma with CAR T Cells
Lymphoma Focus: B-cell Lymphomas, Aggressive Lymphomas
Read full Researcher Spotlight >
Andrew Jallouk, MD, PhD
Errol M. Cook Memorial Scholar
Vanderbilt University Medical Center
Research Study: Tracking and Characterization of Alloreactive T-cells to Improve Allogeneic CAR T-cell Efficacy
Lymphoma Focus: B-cell Lymphomas, Non-Hodgkin Lymphomas
Read full Researcher Spotlight >
Wen-Hsuan Wendy Lin, MD PhD
Columbia University
Research Study: Investigating the mechanistic role of inflammatory signals in peripheral T-cell lymphoma
Lymphoma Focus: Peripheral T-cell Lymphoma
Read full Researcher Spotlight >
Erin Parry, MD, PhD
Dana-Farber Cancer Institute
Research Study: Richter syndrome: Towards early detection of transformation
Lymphoma Focus: B-cell Lymphomas
Read full Researcher Spotlight >
Impact on Research
The Lymphoma Research Foundation (LRF) is committed to funding the most promising lymphoma researchers and advancing the understanding of the more than 100 different subtypes of lymphoma. LRF’s disease-specificity and hyper-focus on finding cures for every type of lymphoma ensure the next generation of cancer researchers dedicate their careers to studying lymphoma, and world-leading lymphoma experts collaborate and accelerate the pace of scientific discovery.